{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/simplifying-and-accelerating-risk-identification-and-assessment-xcellerater-central#webpage",
"url": "https://www.fortrea.com/insights/simplifying-and-accelerating-risk-identification-and-assessment-xcellerater-central",
"name": "Simplifying and accelerating risk identification and assessment with Xcellerate® Central Monitoring",
"description": "This Fortrea case study demonstrates how Xcellerate® Central Monitoring (XCM) supports clinical trial risk management through AI-powered analytics, centralized data review, and proactive monitoring strategies. Clinical trial teams often face challenges associated with fragmented systems, manual review processes, limited visibility into emerging risks, and delayed identification of data anomalies that can affect study quality and compliance. To address these challenges, Fortrea leveraged XCM to analyze data across studies and sites, enabling medical review teams and central monitors to identify inconsistencies, detect emerging risks, evaluate treatment-response trends, review safety reporting patterns, and support timely interventions. Through cross-site data analysis, visualization tools, and near-real-time monitoring capabilities, XCM helped uncover issues that may have been difficult to identify through traditional monitoring approaches alone, allowing teams to strengthen compliance, improve data integrity, enhance oversight, and make more informed operational and clinical decisions. The case study highlights how central monitoring can transform reactive review processes into proactive risk management by providing actionable insights that support quality management throughout the clinical trial lifecycle."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Simplifying and accelerating risk identification and assessment with Xcellerate Risk-Based Quality Management",
"item": "https://www.fortrea.com/insights/simplifying-and-accelerating-risk-identification-and-assessment-xcellerater-central"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/simplifying-and-accelerating-risk-identification-and-assessment-xcellerater-central#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/simplifying-and-accelerating-risk-identification-and-assessment-xcellerater-central#webpage"
},
"headline": "Clinical Trial Risk Management: Detecting Emerging Risks and Improving Data Integrity with Xcellerate® Central Monitoring | Fortrea Case Study",
"description": "This Fortrea case study demonstrates how Xcellerate® Central Monitoring (XCM) supports clinical trial risk management through AI-powered analytics, centralized data review, and proactive monitoring strategies. Clinical trial teams often face challenges associated with fragmented systems, manual review processes, limited visibility into emerging risks, and delayed identification of data anomalies that can affect study quality and compliance. To address these challenges, Fortrea leveraged XCM to analyze data across studies and sites, enabling medical review teams and central monitors to identify inconsistencies, detect emerging risks, evaluate treatment-response trends, review safety reporting patterns, and support timely interventions. Through cross-site data analysis, visualization tools, and near-real-time monitoring capabilities, XCM helped uncover issues that may have been difficult to identify through traditional monitoring approaches alone, allowing teams to strengthen compliance, improve data integrity, enhance oversight, and make more informed operational and clinical decisions. The case study highlights how central monitoring can transform reactive review processes into proactive risk management by providing actionable insights that support quality management throughout the clinical trial lifecycle..",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-04/xcellerate-central-monitoring.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-06",
"dateModified": "2026-04-06",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/xcellerate-central-monitoring-medical-review.pdf",
"encodingFormat": "application/pdf"
}
}
]
}